Business
Ember LifeSciences secures $16.5 million Series A funding to advance breakthrough cold chain solutions for global healthcare
Ember LifeSciences, Inc., a leading provider of revolutionary cold chain technology, today announced a $16.5 million Series A funding round, led by Sea Court Capital, with participation from Cardinal Health, Carrier Ventures and other influential investors, including former U.S. Secretary of State Mike Pompeo. The round underscores strong investor confidence in Ember LifeSciences' ability to redefine global medicine distribution through its proprietary temperature control technology.
About this update from Cardinal Health, Inc.
[{"type":"text","content":"Led by Sea Court Capital, investment round to foster innovation, transform medicine storage","length":91,"tagName":"p","attribs":{}},{"type":"text","content":"LOS ANGELES, Dec. 16, 2025 /PRNewswire/ -- Ember LifeSciences, Inc., a leading provider of revolutionary cold chain technology, today announced a $16.5 million Series A funding round, led by Sea Court Capital, with participation from Cardinal Health, Carrier Ventures and other influential investors, including former U.S. Secretary of State Mike Pompeo. The round underscores strong investor confidence in Ember LifeSciences' ability to redefine global medicine distribution through its proprietary temperature control technology.","length":535,"tagName":"p"},{"type":"image","alt":"Ember Cube 2","displaySize":"","headline":null,"caption":"Ember Cube 2","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":225,"url":"https://media.zenfs.com/en/prnewswire.com/2ea6c5e6b501a3cbe7c294294af9e45d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/vEGolLltdjasmLG3n.AWQA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM5NztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/2ea6c5e6b501a3cbe7c294294af9e45d","width":400,"height":225}},"href":"https://mma.prnewswire.com/media/2846113/Ember_Cube_2.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The global pharmaceutical cold chain ecosystem faces $35 billion in financial loss each year due to temperature excursions, and 330 billion pounds of waste are generated annually from single-use cold chain packaging.","length":216,"tagName":"p"},{"type":"text","content":""Our breakthrough cold chain technology ensures life-saving medicines reach their destination safely, reliably and sustainably," said Clay Alexander, founder and CEO of Ember LifeSciences. "This investment marks a major step forward in advancing the future of healthcare, allowing us to accelerate our next-generation product development, and expand into global markets."","length":391,"tagName":"p"},{"type":"text","content":"This funding will progress Ember LifeSciences' innovation pipeline, including the launch of the Ember Cube 2, which builds off learnings captured from the first-generation Ember Cube, a first-of-its-kind digital shipping box that features cloud-based temperature reporting, GPS location tracking...